Back

OEP
  • Region
    • TW - English
    • TW - 中文
    • Philippines
    • Singapore
    • Malaysia
    • Vietnam
MENU
  • Discover
  • OEP Group
    • OEP Group
    • About OEP
    • About OEP Philippines
    • Milestone
    • Mission & Vision
    • Organization
  • Product Portfolio
    • Products
    • Product Overview
    • Prescription Medicines
    • Dermo-cosmetics
  • Business Development
    • Business Development
    • Business Development
    • Research & Development
    • Partner
  • Overseas Business
  • OEP Subsidiaries
  • Press Center
  • Investors
    • Investors
    • Investors News
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Stakeholder
    • Bank Information
  • CSR
    • CSR
    • CSR Philosophy
    • Charity
    • Environmental Protection
    • Healthy Workplace
  • Careers
    • Careers
    • Talent Development
    • Total Rewards
    • Job Opportunity
  • Link
  • Region
    • TW - English
    • TW - 中文
    • Philippines
    • Singapore
    • Malaysia
    • Vietnam
Financial Information

Financial Information

  • Home
  • Investors

Financial Reports

2020Q4_Unconsolidated Financial Statements
2020Q4_Consolidated Financial Statements
2020Q3_Consolidated Financial Statements
2020Q2_Consolidated Financial Statements
2020Q1_Consolidated Financial Statements
Monthly Revenues Monthly Revenues
Monthly Revenues 2021 January
Market Observation Post System Market Observation Post System
Stock Code: 4120
OEP

Pharma: OEP Philippines

: +63(2)-815-1209

: oepp@oep.com.ph

Unit 606 , SEDCCO 1 Building Rada cor. Legaspi St.
Legaspi Village(1224), Makati City, Philippines

Dermo Cosmetic: Karihome Inc.

: +63(2)-847-0252

: karihome@oep.com.ph

Unit 402 , SEDCCO 1 Building Rada cor. Legaspi St.
Legaspi Village(1224), Makati City, Philippines

  • OEP Group
  • Product Portfolio
  • Business Development
  • Overseas Business
  • OEP Subsidiaries
  • Press Center
  • Investors
  • CSR
  • Careers
  • Link
Terms of Use | Privacy Policy

Copyright ©2021. Orient EuroPharma Co., Ltd. All rights reserved.